Journal for ImmunoTherapy of Cancer · 2025-11-04
1070 The interplay between atopy and immunotherapy: a retrospective analysis
Phrase rank #1 · DOI 10.1136/jitc-2025-SITC2025.1070
Conditions & diseases
cell carcinoma
Observed in 124 articles across 13 journals.
Latest share0.43%
Change vs baseline+0.13 pp
Months observed13
Latest monthJul 2026
Portfolio article share
Attention over this snapshot
13 monthly points
Journal breadth
Where it appears
- Journal for ImmunoTherapy of Cancer79
- BMJ Case Reports26
- BMJ Open4
- Journal of Clinical Pathology4
- BMJ Oncology2
- Gut2
- BMJ1
- BMJ Connections Oncology1
- European Journal of Hospital Pharmacy1
- Frontline Gastroenterology1
- Journal of Medical Genetics1
- Practical Neurology1
Co-occurrence
Explore nearby topics
Inspect the source signal
Article evidence
30 high-ranking examples
BMJ Oncology · 2026-07-02
Looking inside the primary tumour: what drives immunotherapy response in renal cell carcinoma?
Phrase rank #2 · DOI 10.1136/bmjonc-2026-001195
BMJ Case Reports · 2026-06-04
Unexpected aggressiveness in VHL-associated clear cell renal cell carcinoma: insights from two patients highlighting biological heterogeneity
Phrase rank #2 · DOI 10.1136/bcr-2025-270527
Journal for ImmunoTherapy of Cancer · 2026-03-23
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of renal cell carcinoma, version 3.0
Phrase rank #2 · DOI 10.1136/jitc-2025-013788
Journal of Medical Genetics · 2026-03-20
MITF (p.E318K) and renal cell carcinoma: current evidence does not support an effect
Phrase rank #2 · DOI 10.1136/jmg-2025-111119
Journal of Clinical Pathology · 2026-03-19
ELOC-mutant renal cell carcinoma: practical diagnostic features and differential considerations
Phrase rank #2 · DOI 10.1136/jcp-2025-210059
Journal for ImmunoTherapy of Cancer · 2025-11-04
1229 14q deletion in renal clear cell carcinoma is associated with increased anti-tumor immunity and improved response to PD-1 checkpoint blockade potentially driven by NF-κB signaling
Phrase rank #2 · DOI 10.1136/jitc-2025-SITC2025.1229
Journal for ImmunoTherapy of Cancer · 2025-11-04
604 Phase 2 study of neoadjuvant nivolumab + relatlimab versus nivolumab in patients with resectable high-risk basal cell carcinoma
Phrase rank #2 · DOI 10.1136/jitc-2025-SITC2025.0604
BMJ Case Reports · 2025-10-26
Solitary calvarial haemangioma presenting as metastatic renal cell carcinoma
Phrase rank #2 · DOI 10.1136/bcr-2017-223334
BMJ Oncology · 2025-08-17
Novel radiopharmaceuticals for molecular imaging of renal cell carcinoma
Phrase rank #2 · DOI 10.1136/bmjonc-2024-000645
Journal for ImmunoTherapy of Cancer · 2026-07-20
Frontline immunotherapy with response-guided subsequent treatment (FIRST) in cutaneous squamous cell carcinoma: a Bayesian causal analysis of dose intensity, early benefit, and treatment de-escalation
Phrase rank #3 · DOI 10.1136/jitc-2026-015029
BMJ Case Reports · 2026-05-19
Diffuse thyroid metastasis from oropharyngeal squamous cell carcinoma
Phrase rank #3 · DOI 10.1136/bcr-2024-263235
BMJ Case Reports · 2026-04-14
Delayed-onset central adrenal insufficiency following adjuvant pembrolizumab therapy for renal cell carcinoma
Phrase rank #3 · DOI 10.1136/bcr-2025-271276
Journal for ImmunoTherapy of Cancer · 2026-01-30
Single-cell spatial transcriptomics uncovers niches that govern response to PD-1/PD-L1 blockade in cutaneous squamous cell carcinoma
Phrase rank #3 · DOI 10.1136/jitc-2025-014067
Journal for ImmunoTherapy of Cancer · 2025-11-04
529 Exploratory analysis of a phase 2 multicenter study evaluating local immune activation in the tumor microenvironment 12 weeks post VP-315, an investigational therapy for basal cell carcinoma (BCC)
Phrase rank #3 · DOI 10.1136/jitc-2025-SITC2025.0529
Journal of Clinical Pathology · 2025-10-17
Invasion risk of cutaneous squamous cell carcinoma in situ by histological subtype: a retrospective cohort study
Phrase rank #3 · DOI 10.1136/jcp-2024-209608
Journal for ImmunoTherapy of Cancer · 2025-09-09
Artificial intelligence in medical imaging empowers precision neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma
Phrase rank #3 · DOI 10.1136/jitc-2025-012468
Journal of Clinical Pathology · 2026-07-07
Development and internal validation of a multifactorial risk model for predicting disease-free survival in oral squamous cell carcinoma
Phrase rank #4 · DOI 10.1136/jcp-2025-210609
Journal for ImmunoTherapy of Cancer · 2026-05-27
Immunotherapy for early-stage cutaneous squamous cell carcinoma
Phrase rank #4 · DOI 10.1136/jitc-2026-015125
BMJ · 2026-05-14
An ulcerated lesion on the scalp
Phrase rank #4 · DOI 10.1136/bmj-2024-083149
Journal for ImmunoTherapy of Cancer · 2026-04-24
Aging is associated with the outcomes of immune checkpoint blockade in renal cell carcinoma
Phrase rank #4 · DOI 10.1136/jitc-2025-014605
Journal for ImmunoTherapy of Cancer · 2026-04-22
Single-cell dissection of persistent tumor antigens in non-responders reveals opportunities for TAA-targeted vaccination after neoadjuvant therapy in esophageal squamous cell carcinoma
Phrase rank #4 · DOI 10.1136/jitc-2025-014562
BMJ Case Reports · 2026-02-24
Fatal outcome after immunotherapy in metastatic Merkel cell carcinoma of unknown primary cause
Phrase rank #4 · DOI 10.1136/bcr-2025-266245
Journal for ImmunoTherapy of Cancer · 2026-01-14
Cadonilimab (mono anti-PD-1/CTLA-4 therapy) in advanced esophageal squamous cell carcinoma
Phrase rank #4 · DOI 10.1136/jitc-2025-014391
Journal for ImmunoTherapy of Cancer · 2026-01-14
Neoadjuvant lenvatinib plus pembrolizumab in Merkel cell carcinoma: an investigator-initiated, open-label phase II trial
Phrase rank #4 · DOI 10.1136/jitc-2025-013939
BMJ Case Reports · 2025-09-28
Metachronous splenic metastasis from squamous cell carcinoma of the anus
Phrase rank #4 · DOI 10.1136/bcr-2025-266602
BMJ Case Reports · 2025-08-13
Primary squamous cell carcinoma of the breast
Phrase rank #4 · DOI 10.1136/bcr-2023-259343
Journal for ImmunoTherapy of Cancer · 2026-07-09
Clinical significance of CD161+CD8+ T cells in the tumor microenvironment of esophageal squamous cell carcinoma and their association with the 4-1BB signaling pathway
Phrase rank #5 · DOI 10.1136/jitc-2026-014903
Practical Neurology · 2026-07-09
Merkel cell carcinoma metastasis to the brain ventricles
Phrase rank #5 · DOI 10.1136/pn-2026-005292
BMJ Open · 2026-07-07
Abscopal responses following stereotactic ablative radiotherapy during immune checkpoint inhibitor therapy in metastatic renal cell carcinoma: protocol for the prospective multicentre observational AURICRE study in Japan
Phrase rank #5 · DOI 10.1136/bmjopen-2026-118228